高级检索
当前位置: 首页 > 详情页

Cystathionine β-synthase expression correlates with tumor development and poor prognosis in patients with adenocarcinoma of the gastroesophageal junction.

| 导出 |

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE

机构: [1]Department of Thoracic Surgery, Hebei Medical University Fourth Affiliated Hospital, Shijiazhuang 050001, Hebei, China [2]Department of General Surgery, Hebei Provincial People’s Hospital, Shijiazhuang 050055, Hebei, China [3]Department of Chinese Medicine, Hebei Medical University Fourth Affiliated Hospital, Shijiazhuang 050001, Hebei, China [4]Department of Pathology, Hebei Medical University Fourth Affiliated Hospital, Shijiazhuang 050001, Hebei, China [5]Department of Basic Theories of Chinese Medicine, Hebei University of Chinese Medicine, Shijiazhuang 050200, Hebei, China
出处:
ISSN:

关键词: Cystathionine β-synthase adenocarcinoma of the gastroesophageal junction immunohistochemistry

摘要:
To reveal the expression level of cystathionine β-synthase (CBS) in adenocarcinoma of esophagogastric junction (AEG) and discuss the relationship between CBS expression level and tumor microvascular density (MVD), clinical features and prognosis.Paraffin samples from 214 patients with AEG were selected to make pathological microchips. Immunohistochemistry was performed based on the microchips to detect the expression level of CBS and microvascular density (MVD) in cancer tissues and adjacent control tissues. Relationships between expression level of CBS and MVD, clinical characteristics and prognosis were analyzed.In total, 214 AEG cases were classified into three groups: CBS negative staining (n=26), low staining (n=44), and high staining (n=144). Quantitative alterations in CBS and CD31 expression were explored using immunohistochemistry. The 5-year recurrence rate of enrolled patients was followed up and found that CBS expression was significantly increased in tumor tissue compared with adjacent non-tumor tissue (P<0.0001). There were significant differences in microvascular density between the groups with negative and high CBS staining (P<0.0001), and between the groups with low and high CBS staining (P<0.0001). Univariate analysis revealed significant differences in tumor stage (P<0.0001), T stage (P=0.008), N stage (P=0.028), differentiation degree (P=0.037), and 5-year survival (P=0.0034) among the three groups. Multivariate logic regression analysis showed that increased CBS scores were associated with an increased probability of 5-year recurrence (P=0.018). Finally, different CBS expression levels were associated with disease-free survival in AEG patients.CBS expression level is closely related to microvascular density and tumor stage in AEG. High level of CBS not only accelerates tumor angiogenesis but also affects patient's survival and prognosis.AJTR Copyright © 2022.

语种:
WOS:
PubmedID:
中科院分区:
出版当年[2022]版:
大类 | 4 区 医学
小类 | 4 区 肿瘤学 4 区 医学:研究与实验
最新[2025]版:
大类 | 4 区 医学
小类 | 4 区 医学:研究与实验 4 区 肿瘤学
JCR分区:
出版当年[2022]版:
Q4 MEDICINE, RESEARCH & EXPERIMENTAL Q4 ONCOLOGY
最新[2024]版:
Q3 MEDICINE, RESEARCH & EXPERIMENTAL Q4 ONCOLOGY

影响因子: 最新[2024版] 最新五年平均 出版当年[2022版] 出版当年五年平均 出版前一年[2021版] 出版后一年[2023版]

第一作者:
第一作者机构: [1]Department of Thoracic Surgery, Hebei Medical University Fourth Affiliated Hospital, Shijiazhuang 050001, Hebei, China
通讯作者:
通讯机构: [1]Department of Thoracic Surgery, Hebei Medical University Fourth Affiliated Hospital, Shijiazhuang 050001, Hebei, China [5]Department of Basic Theories of Chinese Medicine, Hebei University of Chinese Medicine, Shijiazhuang 050200, Hebei, China [*1]Department of Thoracic Surgery, Hebei Medical University Fourth Affiliated Hospital, 12 Jiankang Road, Shijiazhuang 050001, Hebei, China. [*2]Department of Basic Theories of Chinese Medicine, Hebei University of Chinese Medicine, 209 South Jianhua Street, Shijiazhuang 050200, Hebei, China.
推荐引用方式(GB/T 7714):
APA:
MLA:

相关文献

[1]Cystathionine-β-synthase expression correlates with tumour progression and adverse prognosis in patients with colon cancer [2]Cystathionine β-synthase expression correlates with tumor development and poor prognosis in lung squamous cell carcinoma patients. [3]对食管胃交界腺癌的认识和争议 [4]The safety and usefulness of neutron brachytherapy and external beam radiation in the treatment of patients with gastroesophageal junction adenocarcinoma with or without chemotherapy [5]Feasibility Analysis of Involved-Field Irradiation in Patients With Locally Advanced Adenocarcinoma of the Gastroesophageal Junction in Siewert's Type 2 and 3 Undergoing Preoperative Concurrent Chemoradiation Therapy [6]Randomized, double-blind, placebo-controlled phase III trial of apatinib in patients with chemotherapy-refractory advanced or metastatic adenocarcinoma of the stomach or gastroesophageal junction [7]Feasibility Analysis of Involved-Field Irradiation in Patients With Locally Advanced Adenocarcinoma of the Gastroesophageal Junction in Siewert's Type 2 and 3 Undergoing Preoperative Concurrent Chemoradiation Therapy [8]局部进展期GEJA综合治疗的现状与思考 [9]Safety and efficacy of apatinib in patients with advanced gastric or gastroesophageal junction adenocarcinoma after the failure of two or more lines of chemotherapy (AHEAD): a prospective, single-arm, multicenter, phase IV study [10]胱硫氨酸beta-合成酶在食管胃结合部腺癌中的表达及其临床意义

资源点击量:42313 今日访问量:0 总访问量:1365 更新日期:2025-08-01 建议使用谷歌、火狐浏览器 常见问题

技术支持:重庆聚合科技有限公司 地址:河北省石家庄市健康路12号